NVIDIA CORP
Institutional investor · Portfolio as of Q2 2025
Top Holdings6 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
COREWEAVE INC-CL A | 24.3M | $4B | 91.4% | $40.47 | +295.33% | 2 qtrssince 2025-Q1 | Increased 65 |
ARM Holdings PLC Sponsored ADR | 1.1M | $178.1M | 4.1% | $75.14 | +120.20% | 7 qtrssince 2023-Q4 | Unchanged 0 |
APPLIED DIGITAL CORP | 7.7M | $77.7M | 1.8% | $8.19 | +26.74% | 4 qtrssince 2024-Q3 | Unchanged 0 |
NEBIUS GROUP NV | 1.2M | $65.9M | 1.5% | $26.92 | +92.57% | 3 qtrssince 2024-Q4 | Unchanged 0 |
RECURSION PHARMACEUTICALS IN | 7.7M | $39M | 0.9% | $9.86 | -48.99% | 7 qtrssince 2023-Q4 | Unchanged 0 |
WERIDE INC | 1.7M | $13.7M | 0.3% | $13.85 | -42.02% | 3 qtrssince 2024-Q4 | Unchanged 0 |
NVIDIA CORP manages $4.3B across 6 positions as of Q2 2025. Top holdings: CRWV (91.4%), ARM (4.1%), APLD (1.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Increased 1. Top move: CRWV (INCREASED, conviction 65). Portfolio: $4.3B across 6 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer